Morrison & Foerster LLP advised Krystal Biotech on the deal. Krystal Biotech, Inc. announced its $143.75 million common stock offering at $65 per share. Goldman Sachs…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now